INR 6090.0
(-0.54%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.69 Billion INR | -45.55% |
2022 | 8.73 Billion INR | -5.22% |
2021 | 9.22 Billion INR | -6.06% |
2020 | 9.81 Billion INR | -10.7% |
2019 | 10.99 Billion INR | 2.37% |
2018 | 10.73 Billion INR | 4.28% |
2017 | 10.29 Billion INR | 19.87% |
2016 | 8.58 Billion INR | 5.61% |
2015 | 8.13 Billion INR | 9.77% |
2014 | 7.4 Billion INR | 10.94% |
2013 | 6.67 Billion INR | 9.77% |
2012 | 6.08 Billion INR | 32.87% |
2011 | 4.57 Billion INR | 47.76% |
2010 | 3.09 Billion INR | 23.63% |
2009 | 2.5 Billion INR | 1.67% |
2008 | 2.46 Billion INR | 35.79% |
2007 | 1.81 Billion INR | -11.31% |
2006 | 2.04 Billion INR | 6.59% |
2005 | 1.92 Billion INR | 3.68% |
2004 | 1.85 Billion INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 665 Million INR | -40.99% |
2024 Q1 | 1.12 Billion INR | -16.08% |
2023 Q2 | 2.21 Billion INR | 4.58% |
2023 Q1 | 2.11 Billion INR | 11.54% |
2023 FY | 4.75 Billion INR | -45.55% |
2023 Q4 | 1.34 Billion INR | -37.97% |
2023 Q3 | 2.16 Billion INR | -2.21% |
2022 FY | 8.73 Billion INR | -5.22% |
2022 Q3 | 2.31 Billion INR | 0.78% |
2022 Q4 | 1.89 Billion INR | -17.87% |
2022 Q1 | 2.23 Billion INR | -3.24% |
2022 Q2 | 2.29 Billion INR | 2.5% |
2021 Q4 | 2.31 Billion INR | -2.78% |
2021 Q1 | 2.31 Billion INR | 4.51% |
2021 FY | 9.22 Billion INR | -6.06% |
2021 Q2 | 2.21 Billion INR | -4.57% |
2021 Q3 | 2.37 Billion INR | 7.5% |
2020 FY | 9.81 Billion INR | -10.7% |
2020 Q1 | 2.88 Billion INR | 15.04% |
2020 Q2 | 2.37 Billion INR | -17.69% |
2020 Q3 | 2.34 Billion INR | -1.35% |
2020 Q4 | 2.21 Billion INR | -5.25% |
2019 FY | 10.99 Billion INR | 2.37% |
2019 Q1 | 2.81 Billion INR | 11.56% |
2019 Q2 | 2.74 Billion INR | -2.41% |
2019 Q3 | 2.91 Billion INR | 6.18% |
2019 Q4 | 2.5 Billion INR | -14.15% |
2018 Q4 | 2.52 Billion INR | -7.54% |
2018 Q1 | 1.21 Billion INR | -51.54% |
2018 FY | 10.73 Billion INR | 4.28% |
2018 Q2 | 2.69 Billion INR | 122.89% |
2018 Q3 | 2.73 Billion INR | 1.26% |
2017 Q4 | 2.49 Billion INR | -4.15% |
2017 Q3 | 2.6 Billion INR | -1.18% |
2017 Q2 | 2.63 Billion INR | 8.93% |
2017 Q1 | 2.42 Billion INR | -14.91% |
2017 FY | 10.29 Billion INR | 19.87% |
2016 Q1 | 2.1 Billion INR | 13.51% |
2016 FY | 8.58 Billion INR | 5.61% |
2016 Q2 | 2.16 Billion INR | 2.8% |
2016 Q4 | 2.84 Billion INR | 25.56% |
2016 Q3 | 2.26 Billion INR | 4.47% |
2015 Q1 | 1.92 Billion INR | -3.08% |
2015 FY | 8.13 Billion INR | 9.77% |
2015 Q2 | 1.9 Billion INR | -0.73% |
2015 Q3 | 2.07 Billion INR | 8.97% |
2015 Q4 | 1.85 Billion INR | -10.54% |
2014 Q3 | 1.82 Billion INR | -1.56% |
2014 Q4 | 1.98 Billion INR | 8.49% |
2014 FY | 7.4 Billion INR | 10.94% |
2014 Q1 | 1.74 Billion INR | 4.16% |
2014 Q2 | 1.85 Billion INR | 6.18% |
2013 FY | 6.67 Billion INR | 9.77% |
2013 Q1 | 1.63 Billion INR | -33.82% |
2013 Q2 | 1.71 Billion INR | 4.89% |
2013 Q3 | 1.71 Billion INR | -0.17% |
2013 Q4 | 1.67 Billion INR | -2.09% |
2012 Q4 | 2.47 Billion INR | 60.84% |
2012 Q1 | 1.35 Billion INR | 19.54% |
2012 FY | 6.08 Billion INR | 32.87% |
2012 Q2 | 1.57 Billion INR | 16.28% |
2012 Q3 | 1.53 Billion INR | -2.16% |
2011 FY | 4.57 Billion INR | 47.76% |
2011 Q2 | 787 Million INR | 0.0% |
2011 Q3 | 707 Million INR | -10.17% |
2011 Q4 | 1.13 Billion INR | 59.86% |
2010 FY | 3.09 Billion INR | 23.63% |
2009 FY | 2.5 Billion INR | 1.67% |
2008 FY | 2.46 Billion INR | 35.79% |
2007 FY | 1.81 Billion INR | -11.31% |
2006 FY | 2.04 Billion INR | 6.59% |
2005 FY | 1.92 Billion INR | 3.68% |
2004 FY | 1.85 Billion INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Abbott India Limited | 5.98 Billion INR | 38.308% |
Cipla Limited | 59.21 Billion INR | 93.764% |
Gland Pharma Limited | 3.86 Billion INR | 4.366% |
GlaxoSmithKline Pharmaceuticals Limited | 4.35 Billion INR | 15.247% |
Kopran Limited | 859.54 Million INR | -329.644% |
Marksans Pharma Limited | 3.28 Billion INR | -12.268% |
NGL Fine-Chem Limited | 816.16 Million INR | -352.483% |
Pfizer Limited | 4.33 Billion INR | 14.853% |
SMS Pharmaceuticals Limited | 370.89 Million INR | -895.705% |